1. Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)

   • Ajay Duseja
   • Naga Chalasani

   Review Article 02 November 2013 Pages: 755 - 764

2. Current histological classification of NAFLD: strength and limitations

   • Pierre Bedossa

   Review Article 18 July 2013 Pages: 765 - 770

3. Immune and inflammatory pathways in NASH

   • Michal Ganz
   • Gyongyi Szabo

   Review Article Open access 30 August 2013 Pages: 771 - 781

   

4. Insulin resistance, steatosis and hepatitis C virus

   • Alessandra Mangia
   • Maria Ripoli

   Review Article Open access 27 August 2013 Pages: 782 - 789

5. Hard clinical outcomes in patients with NAFLD

   • Ramesh Kumar

   Review Article 06 August 2013 Pages: 790 - 799

   

6. An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis

   • Arun J. Sanyal

   Review Article 27 December 2013 Pages: 800 - 805

   

7. Lean NASH: distinctiveness and clinical implication

   • Kausik Das
   • Abhijit Chowdhury

   Review Article 17 October 2013 Pages: 806 - 813

   

8. Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH

   • Luca Montesi
   • Arianna Mazzotti
   • Giulio Marchesini

   Review Article 31 July 2013 Pages: 814 - 822

   

9. Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific

   • Roslyn Vongsuvanh
   • David van der Poorten
   • Jacob George

   Review Article 31 July 2013 Pages: 823 - 832

   

10. Pharmacological agents for nonalcoholic steatohepatitis

    • Maeva Guillaume
    • Vlad Ratziu

    Review Article 19 November 2013 Pages: 833 - 841